A software program [MU-EPID], has been developed to perform patient specific pre-treatment quality assurance (QA) verification for intensity modulated radiation therapy (IMRT) using fluence maps measured with an electronic portal imaging device (EPID). The software converts the EPID acquired images of each IMRT beam, to fluence maps that are equivalent to those calculated by the treatment planning system (TPS). The software has the capability to process Varian, Elekta and Siemens EPID DICOM images. In the present investigation, several IMRT plans for different treatment sites were used to validate the software using the Varian a-Si 1000 EPID with the Pinnacle TPS. A total of 20 IMRT plans of different treatment sites were analyzed. Isodose distributions, dose profiles, dose volume histograms (DVH's) and gamma analysis comparisons were performed to evaluate the accuracy of our method. A gamma index analysis of the isocenter coronal plane was done for each plan and showed an average of 97.44% of gamma passing rate using a 3% and 3 mm gamma criterion. Isodose, DVH and dose profile comparisons were conducted between the original calculated plan and the measured reconstructed plan from the EPID images processed through the MU-EPID software. The results suggest that MU-EPID can be used clinically for patient specific IMRT QA, providing a comprehensive 3D dosimetric evaluation through DVH comparison as well as an option for a 2D gamma analysis.
Introduction
The electronic portal imaging device (EPID) was originally developed for the purpose of verifying the patient daily/weekly setup prior to radiation therapy. The high resolution images acquired by an amorphous-silicon (aSi) EPID has afforded us the option to augment its use and to integrate the EPID as a planar dosimeter in routine linear accelerator (linac) quality assurance (QA) (1) .
Most modern linear accelerators are outfitted with an EPID that is capable of collecting images in both integrated and continuous mode. It is possible, as has been shown already in the literature (2, 3, and 25) , to use the EPID images of an open field or an intensity modulated radiation therapy (IMRT) beam to reconstruct the dose in the patient anatomy or in a phantom. This requires a de-convolution and back-projection of the images, followed by a forward ray-trace in the patient Technology in Cancer Research & Treatment, Volume 13, Number 1, February 2014 anatomy for the calculation of dose. In our present work, we introduce an in-house software called MU-EPID which has been developed as an optimized and integrated solution with the treatment planning system (TPS) to perform EPID based pre-treatment IMRT QA. The software functionality and the work flow will be presented along with examples of its application. A validation study to benchmark MU-EPID was conducted for a Varian Novalis TX machine using a number of patient specific IMRT QA plans.
Several researchers have investigated the use of electronic portal imaging devices for quality assurance purposes such as MLC position verification (16) (17) (18) and IMRT patient specific dose verification (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) . Renner et al. (24) reported on four different methods that have been introduced for the purpose of using the EPID for treatment verification: 1) Compute the dose from each beam to the EPID and compare to the actual EPID image of each beam (4-15); 2) Use the EPID to verify the leaf positions for intensity modulated fields (16) (17) (18) ; 3) Reconstruct the dose to the patient using the exit image acquired during treatment (20-23); and 4) Convert the EPID images to an incident fluence distribution and use it for dose calculation employing the patient CT anatomy (24, 25) .
The present investigation is a variant of the fourth method and consists of converting the EPID images to a fluence map, based on the images acquired for each of the fields of the patient's treatment plan. For every beam, the measured fluence is used as input to the treatment planning system to perform a dose calculation in the patient anatomy. By doing so, we use the same dose calculation algorithm for both the initial treatment plan and for the patient specific pretreatment QA. This allows us to eliminate any dose algorithm specific variations for the comparison of the initial plan and the EPID-based reconstructed plan. Furthermore, we maintain the integrity of the original treatment beam geometry and we use the same evaluation tools for the dosimetric analysis of both plans. Consequently, any changes in the plan quality between the physician approved and delivered plan will be attributed to errors introduced by the delivery since all other parameters are kept constant.
Some of the limitations for using the EPID as a dose verification tool are imposed by the limited size of the detector that dictates the maximum field that can be captured by the EPID system. For patient specific IMRT QA, the main limitation is the size of the fluence distribution captured and imported into the TPS for the dose calculation. For the Pinnacle system, the maximum size of the fluence map that can be calculated based on EPID measurements is a 25 3 25 cm 2 field. In order to accurately take into account the penumbra region of the IMRT field, a maximum field size of 22 3 22 cm 2 is recommended in our implementation.
Materials and Methods
The functionality and capabilities of four different EPID systems were incorporated into the MU-EPID software; namely, the Varian aSi-1000 (Varian Medical System, Inc., Palo Alto, CA), the Varian Portal Imager aSi-500, the Elekta iView (Elekta AB, Stockholm, Sweden), and the Siemens Beamview Coherence electronic portal imaging system (Siemens Oncology Care System). To validate our software for IMRT QA, we used a Varian aSi-1000 mounted on a Varian Novalis TX linear accelerator with a 120 HD-MLC (Varian Medical System, Inc., Palo Alto, CA). Table I shows a comparison between some of the features of the systems used to validate the MU-EPID software for patient specific IMRT QA. The Elekta linac could only be programmed for a source to detector distance (SDD) of 160 cm; for the other EPIDs, the smallest value of the pre-programmed SDD for each linac was used for all our measurements. Using the pre-programmed EPID position stations, we enforced consistency and reproducibility throughout our experiments. However, any SDD can be selected as long as all the calibrations and measurements are obtained at the same SDD for all patient IMRT QA related measurements. In this paper, we will share our experience with the Varian Novalis TX linac with the 120 HD-MLC and the aSi-1000 EPID. Dose reconstruction using an EPID presents many challenges, including: a) the EPID response dependence on energy, b) the effect on the image from the backscatter attributed to the EPID support arm, c) transmission associated with the MLC tongue and grove effect, and d) MLC interleaf leakage. In the present study, the energy dependence response of the EPID has been incorporated by obtaining calibration images for every beam energy and by constructing a unique calibration curve that is linac and energy specific. The EPID support arm backscatter is not directly included in our implementation. However, Rowshanfarzad et al. (30) have described an easy method for obtain EPID images using a piece of lead that blocks the backscatter, thus improving upon the accuracy of the dose reconstruction.
The simplified version of their method can be implemented as part of the measurement and potentially improve the 2D gamma analysis. Because of volume averaging effect and in Figure 1 . The units of the gray scale value for the Varian EPID DICOM images are CU calibrated units (signal).
The response of the EPID as shown in Figure 1 is linear and consequently, in the software application we use a single 10 3 10 cm 2 field exposure with 100 MU to obtain the calibration curve. Figure 2 shows a screen capture from the software with the EPID image and the corresponding calibration curve for 100 MU irradiation. Two regions of interest (ROI) are automaticlaly identified by the software: one in the center of the image and on in the bottom left corner of the image. The average value of the central ROI is used as the EPID response for the 100 MU irradiation, whereas the bottom left ROI is used as the EPID response for no irradiation. This calibration curve is subsequently applied to all IMRT field measurements performed on that same day for a given energy, to convert the EPID signal to MU equivalent relative units.
EPID Images Conversion to Fluence
In order to use the EPID images in the TPS, it is necessary to convert them to a format that can be recognized by the TPS.
Once the EPID images are converted to MU equivalent relative units they get re-normlalized and subsequently imported into the TPS. Figure 3 shows the GUI of the IMRT QA routine of the software. Once the patient is selected and the IMRT QA is scatter re-distribution, the effect is expected to be smaller in our 3D dose reconstruction method, although this was not investigated in this study. The MLC tongue-and-groove effect, as well as the interleaf leakage effect, have not been separated out from the EPID image in our implementation, because they are considered to be part of the fluence that is convolved with the patient. As such, they are included in the fluence map that we ray-trace through the patient anatomy when calculating the dose.
The MU-EPID software has been developed using Matlab version 9.0. The graphical user interface (GUI) has two principle functions which are a) EPID image calibration and b) IMRT QA.
Step wedge and uniform irradiation are the two options currently implemented for the calibration of the system. The IMRT QA routine includes the IMRT processing function where the DICOM images from the EPID are processed and converted to fluence maps for the TPS dose calculation. An IMRT evaluation function is available for dose profile comparison and for planar dose difference and gamma analysis between the measured and TPS exported planar doses.
EPID Linearity Test
To investigate the response of the EPID with respect to the dose delivered, a step wedge field was used to deliver 10 steps of incremental MUs, ranging from 20 to 200 MU. The EPID response of the Varian aSi-1000 EPID is shown opened, all the EPID images of the selected patient populate the "Field summary" box. The software automatically distinguishes between the Varian, Elekta and Siemens EPID format by reading the header of the image file. In addition, parameters such as the gantry and couch angle are directly read in from the EPID DICOM files imported. Although the EPID image acquisition for all IMRT fields is done with the couch retracted, the couch angle is displayed in the GUI A dark-field and flood-field calibration is performed according to the recommendations of the EPID manufacturer. Such calibration produces a suppression of the flattening filter effect in routine EPID imaging (24) . A 2D array correction factor is incorporated into the software which takes into account the residual effect of the flattening filter (beam horns) which is seen in the EPID images. This matrix correction can be obtained in three different ways: First, by taking in-air profile measurements of a large, open beam, at SDD with an ion chamber. Second, by following the method proposed by Greer (31) consisting of measuring the off-axis response by acquiring off-axis raw images and dividing out the off-axis beam fluence and previously determined pixel sensitivity differences. Lastly, by using an EPID image of an open beam for the largest field size allowed at the nominal SDD and process the image through our software by comparing it to the TPS calculation for the same field. The ratio of the EPID to the TPS normalized planar images yields the 2D array corection factor. The third method is what has been implemented in our software. Figure 4 summarizes the work flow for the IMRT QA in MU-EPID. Once the treatment plan is approved, it is sent to the record and verify (RV) system for pre-treatment delivery. The beams are delivered to the EPID with no phantom in the beam path. EPID images are acquired in the integrated or continuous (cine) mode of acquisition (rate of 7.5 frames per second for the aS1000) for each beam. Once the beam delivery is complete, the images are exported in DICOM format for the Varian and Siemens systems, and in HIS file format for the Elekta system. The EPID DICOM images are converted into fluence maps in the appropriate TPS format and exported to the TPS. The imported fluence is used to calculate the dose in the patient CT and the dose is compared to the patient's original treatment plan. Isodose and dose volume histogram (DVH) comparison between the two plans can be performed using the TPS plan comparison and evaluation tools. Comparison of planar doses is available through the MU-EPID software after the plan and QA planar doses are exported for analysis back to MU-EPID.
EPID-IMRT QA Process

MU-EPID Software Validation
In order to validate the dose calculation based on EPID images, twenty two (n 5 22) step and shoot IMRT patient Figure 5 ), also commonly known as the "cheese" phantom; it is a quality assurance phantom that is included with the TomoTherapy ® Hi-Art ® (TomoTherapy, Inc., Madison, WI). The radius of the phantom is 15 cm and it is 18 cm in length. Ion chamber measurements were performed at 1 cm below the equator of the phantom which was set to the isocenter of the LINAC. The Exradin A1SL ionization chamber coupled with a K602 electrometer model were used for the measurements. The corresponding EPID measurements for the validation study were obtained using an aSi-1000 EPID mounted on a Varian Novalis LINAC equipped with HD 120 MLC. The EPID measurements were obtained by delivering the patient specific IMRT beams without the "cheese" phantom as shown in Figure 5 .
MU-EPID IMRT Patient Specific QA
The fluence maps generated by MU-EPID were used to compute the dose using the patient CT anatomy and compared against the patient's original treatment plan. This method has the advantage of using the actual patient anatomy to show a comparison between the treatment plan that was developed to treat the patient and the treatment plan that is derived from the measured fluence maps of each treatment beam. In essence, we are using the RTP system as a display and analysis platform to compare two plans for each IMRT patient: the plan that the physician approved for treatment and the plan that is derived from measurements of the same beams. Such comparison allows us to take advantage of all the plan evaluation and comparison tools in the planning system such as isodose display, dose profiles, DVH and region of interest dose statistics. It is a true 3D dose distribution comparison that is not subject to algorithmic differences between the original plan and the reconstructed plan, since they both used the TPS as the common platform for dose calculation, display and analysis.
Results
Results are going to be divided into the software validation study and the patient specific IMRT QA using EPID images.
The purpose of the validation study was to compare the dose calculated by the MU-EPID against the measured point dose that was obtained with an ionization chamber inserted in the same cylindrical phantom. Subsequently, a set of patient specific IMRT QA measurements were obtained and analyzed using the MU-EPID, to test the software in a clinically relevant setting.
Software Validation Study
Results of the validation study between ionization chamber measurements and EPID based dose calculations are presented in Figure 6 . Only one of the 22 IMRT cases showed a dose difference larger than 5% when compared to the ion chamber measurement. An average of 1.9 percent difference between the TPS dose calculation and the EPID based QA was obtained from all the 22 IMRT cases that we examined, while a 0.1 percent deference between the TPS dose calculation and the ion chamber measurements was observed.
EPID IMRT Patient Specific QA
A total of 20 IMRT clinical cases for different treatment sites were used for the patient specific quality assurance evaluation with MU-EPID. Comparisons between the coronal planar dose calculated by the TPS and the EPID based method were conducted using a gamma criterion of 3% dose difference and 3 mm distance to agreement to evaluate the performance of the software. Figure 7 shows the DVH comparison of a head and neck clinical case processed with MU-EPID and compared against the clinical TPS dose calculation that was used for treatment. Figures 8 and 9 show the isodose comparison for the same head and neck clinical case and the results of the gamma analysis respectively. An average of 97.44% of gamma passing points were obtained for all the clinical cases we studied, based on a gamma pass-fail criterion of 3% and 3 mm. The MU-EPID software has also been tested for an Elekta and Siemens machine with similar results to those presented for the Varian LINAC. More specifically, an ELEKTA iView and a Siemens Coherence system were used with three IMRT patients. The low number of patients tested in those two accelerator platforms is because of our limited access to those linacs. Dose reconstruction as well as volumetric and 2D analysis was performed. Using the 3% and 3 mm pass-fail gamma criteria, we obtained a passing rate in the range of 95.4%-99.1% for all the patients examined. 
Discussion
In this investigation, we have introduced an in-house developed software, MU-EPID, and have demonstrated its use as a patient specific pre-treatment IMRT quality assurance tool. Although the results for the combination of a Varian aS100 EPID on a Novalis TX linac and the Pinnacle TPS were presented in this paper, similar results were obtained for images from the Elekta and Siemens EPIDs respectively. The software supports both the Philips-Pinnacle TPS as well as the Varian-Eclipse TPS. We have found that as one would intuitively expect, a critical aspect in the successful implementation of an EPID as an instrument for dose reconstruction, is the proper functionality and calibration of the device. The dark and flood fields have to be collected per manufacturer specifications because a drift in the response of the EPID can change the recorded signal and consequently the accuracy of the dose reconstruction. Additionally, as was described in the Methods section, a calibration image needs to be obtained for every instance that the MU-EPID will be used for clinical dosimetry so that the clinical images can be converted to fluence maps. The MLC tongue-and-groove effect, as well as the interleaf leakage effect, contribute to the fluence that is captured in the EPID image. Although this fluence map is back-projected to reconstruct the primary fluence array, the tongue and grove and leakage effects are not explicitly modeled by the RTP system which may contribute to the differences observed in the gamma analysis.
MU-EPID has the advantage of enabling the user to reconstruct the dose to the patient by using the fluence maps measured with the EPID. The planner can then compare isodose distributions, DVHs and ROI statistics for the reconstructed and originals treatment plans from within the planning system. A unique feature of MU-EPID is that it converts the EPID images to fluence maps that are then transferred back to the TPS to calculate the reconstructed dose. The use of the same computational platform to perform the dose calculation for the original patient plan and for the dose reconstruction, removes any ambiguities related to dose algorithm differences when comparing the two plans. The algorithm itself, as well as secondary factors such as dose grid size, resolution of calculation, ROI segmentation and calculation of DVH can introduce differences between two plans even if the fluence maps are identical. By integrating the functionality of MU-EPID with the TPS, we remove the source for such potential discrepancies. The flip side of that is that the dose calculation is not independent of the planning system although the fluence is derived from measurement.
Finally, the time it takes to perform the data processing and conversion in MU EPID and transfer the data back to the TPS is less than a minute. The speed of the analysis, is almost entirely dictated by the TPS speed and the number of beams and parameters used in the planning system. For a typical 5 field IMRT plan, once the fluence maps have been measured, the MU-EPID analysis, TPS calculation and plan comparison takes on average three minutes using the Pinnacle Enterprise TPS platform.
Conclusion
We have described the functionality and features of an inhouse developed EPID based dose reconstruction application for pre-treatment IMRT patient QA. The software is interfaced with the TPS and allows the user to perform a comprehensive, three-dimensional evaluation of the delivered and originally planned treatment using the patient's simulation CT scan. Our early clinical experience with the system, demonstrates that we can reproducibly get better than 95% agreement between the measured and planned dose distributions, both in the 3D analysis and in the 2D analysis using the gamma index.
